Ireland
--:--IST
Starting soon Observational

Soft Tissue Physical Properties in Long-Distance Runners

NCT06607315 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2024-10-15
Last updated
2024-10-10

Condition(s) studied

Runner

Investigational drug(s) / intervention(s)

physical properties of soft tissueAnalysis of Running Form

physical properties of soft tissue: Using the Myoton Pro device, the physical properties such as elasticity and viscosity of the Achilles tendon, patellar tendon, gastrocnemius, quadriceps, and hamstring muscles will be measured.

Analysis of Running Form: High-speed camera systems will be used to analyze biomechanical parameters in detail, such as angular movements of the lower extremity joints (tibia, ankle, knee, hip), step length, and ground contact time during running. These analyses will allow us to objectively characterize different running forms.

Study summary

The aim of this study is to investigate in greater depth the effects of different running forms on soft tissue physical properties in long-distance runners and the relationship of this to injury risk. By doing so, the study seeks to provide new insights into the pathophysiology of running injuries and develop more effective injury prevention strategies.

Eligibility

Sex
ALL
Min age
25 Years
Max age
35 Years
Healthy volunteers
Accepted
Inclusion Criteria: * individuals who have been regularly running long distances for at least 1 year, * between the ages of 25 and 35, * classified as amateur athletes Exclusion Criteria: * Having undergone orthopedic surgery involving the lower extremity

Primary outcome measure(s)

  • myoton pro device — 3 months
    the physical properties of the tendon will be measure
  • running form analysis — 3 months
    High-speed camera systems will be used to analyze biomechanical parameter of lower extremity

Trial sites (1)

FacilityCityRegionStatus
Gamze Aydın Istanbul Turkey (Türkiye)
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06607315 on ClinicalTrials.gov ↗ ← All trials in Turkey